Aerovate Therapeutics Inc Stock

$2.57

0.20% yesterday

Nasdaq, Nov 15, 09:49 pm CET

ISIN

US0080641071

Symbol

AVTE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Aerovate Therapeutics Inc Stock price

$2.53

-20.30 88.92% 5Y

Nasdaq, Closing price Fri, Nov 15 2024

-0.03 1.17%

ISIN

US0080641071

Symbol

AVTE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$73.90m
Enterprise Value	$-14.29m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	0.19
P/B ratio (TTM) P/B ratio	0.92
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-90.26m
Free Cash Flow (TTM) Free Cash Flow	$-75.01m
Cash position	$88.73m
EPS (TTM) EPS	$-3.00
P/E forward	negative
Short interest	4.85%

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Get Started for Free Today

Aerovate Therapeutics Inc Stock Analysis

Unlock Scores for Free

??

5 Analysts have issued a Aerovate Therapeutics Inc forecast:

5x Hold

100%

More details on Analyst Estimates Including Price Targets

5 Analysts have issued a Aerovate Therapeutics Inc forecast:

Hold

100%

Analyst Estimates with Stock Price Targets

Financial data from Aerovate Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	- -	- 100%
- Direct Costs	0.30 0.30	233% 233% -
Gross Profit	-0.30 -0.30	233% 233% -
- Selling and Administrative Expenses	20 20	23% 23% -
- Research and Development Expense	69 69	18% 18% -
EBITDA	-90 -90	20% 20% -
- Depreciation and Amortization	0.30 0.30	233% 233% -
EBIT (Operating Income) EBIT	-90 -90	20% 20% -
Net Profit	-85 -85	21% 21% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Aerovate Therapeutics Inc Stock News

Neutral

Business Wire

●

11 days ago

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerovate Therapeutics, Inc. (NasdaqGM: AVTE) and Jade Biosciences. Pursuant to the terms of the agreement, shareholders of Aerovate will own approximately 1.6% of the combined company. KSF is seeking to determin...

Neutral

PRNewsWire

●

14 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders

NEW YORK , Nov. 1, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerovate Therapeutics, Inc. (NASDAQ: AVTE)'s merger with Jade Biosciences. Upon closing of the proposed transaction, Aerovate stockholders are expe...

Neutral

Business Wire

●

16 days ago

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aerovate Therapeutics, Inc. (NASDAQ: AVTE) and Jade Biosciences is fair to Aerovate shareholders. Upon closing of the proposed transaction, Aerovate stockholders are expected to own approximately 1.6% of the combined company. Halper Sadeh encourages Aerovate shareholders to click her...

More Aerovate Therapeutics Inc News

Company Profile

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focus on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake in July 27, 2018 and is headquartered in Boston, MA.

Head office	United States
CEO	Timothy Noyes
Employees	51
Founded	2018
Website	www.aerovatetx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now